Mavacamten is a selective, reversible, allosteric cardiac myosin inhibitor. It is approved under the brand name Camzyos ® for the treatment of adults with symptomatic New York Heart Association class ...
The company behind a gondola lift and other leisure attractions on Swansea ’s Kilvey Hill said it took its responsibility to ...
Gold X2 Mining Inc. (TSXV: AUXX) (OTCQB: GSHRF) (FSE: DF8) (“Gold X2” or the “Company”), is pleased to announce that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback